Nasacort and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasacort (triamcinolone acetonide) and Neupogen (filgrastim). Common drug interactions include bone density decreased among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Nasacort and Neupogen. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 18, 2026

60 people who take Nasacort and Neupogen together, and have interactions are studied.

Nasacort and Neupogen drug interactions.

What are the common drug interactions of Nasacort and Neupogen, by gender? *:

female:

Bone density decreased
Bone disorder
Colitis (inflammation of colon)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Fistula (an abnormal connection or passageway between two)
Hypoaesthesia (reduced sense of touch or sensation)
Impaired healing
Lung neoplasm malignant (cancer tumour of lung)
Nausea (feeling of having an urge to vomit)
Neoplasm (tumour)

male:

Pain
Lymphadenopathy (disease or enlargement of lymph nodes)
Cataract (clouding of the lens inside the eye)
Decreased appetite
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Deformity (disfigurement)
Device related infection
Gastritis (inflammation of stomach)
Haemangioma of liver (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in liver)
Haematuria (presence of blood in urine)

What are the common drug interactions of Nasacort and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Lung neoplasm malignant (cancer tumour of lung)
Neoplasm (tumour)
Neuropathy peripheral (surface nerve damage)
Oedema peripheral (superficial swelling)
Ovarian cancer (cancer of ovary)
Platelet count decreased
Soft tissue disorder (disease of soft tissue)
Swelling
Tenderness (pain or discomfort when an affected area is touched)
Tooth disorder (tooth disease)

60+:

Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Oedema peripheral (superficial swelling)
Skin discolouration (change of skin colour)
Skin induration (an abnormally hard spot or area on the skin)
Burning sensation
Chronic lymphocytic leukaemia transformation (white blood cell cancer changes in fast growing cancer in lymph node)
Coombs positive haemolytic anaemia
Cytomegalovirus infection
Pain
Thermal burn (burn by heat)

What are the existing conditions these people have? *

Breast Cancer: 24 people, 40.00%
Discomfort: 23 people, 38.33%
Ovarian Cancer (cancer of ovary): 23 people, 38.33%
Neoplasm Malignant (cancer tumour): 23 people, 38.33%
Breast Cancer Metastatic: 23 people, 38.33%
Migraine (headache): 23 people, 38.33%
Hot Flush (sudden feelings of heat): 23 people, 38.33%
Granulocyte Count Decreased: 23 people, 38.33%
Multiple Myeloma (cancer of the plasma cells): 17 people, 28.33%
Thyroid Cancer: 5 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Nasacort and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously